Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director
|
Silo Pharma, Inc. (UCUT)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/29/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
03/27/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
02/03/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
01/31/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
01/20/2023 |
8-K
| Other Events Interactive Data |
12/01/2022 |
8-K
| Quarterly results |
10/18/2022 |
8-K
| Quarterly results |
09/30/2022 |
8-K
| Quarterly results |
09/15/2022 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits ... |
03/11/2022 |
8-K
| Quarterly results |
03/07/2022 |
8-K
| Quarterly results |
01/04/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
10/27/2021 |
8-K
| Entry into a Material Definitive Agreement Interactive Data |
09/27/2021 |
8-K
| Quarterly results |
08/18/2021 |
8-K
| Quarterly results |
07/12/2021 |
8-K
| Quarterly results |
06/07/2021 |
8-K
| Quarterly results |
04/28/2021 |
8-K
| Quarterly results |
04/16/2021 |
8-K
| Quarterly results |
04/07/2021 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
03/12/2021 |
8-K
| Quarterly results |
02/16/2021 |
8-K
| Quarterly results |
02/12/2021 |
8-K/A
| Quarterly results |
02/10/2021 |
8-K
| Quarterly results |
01/28/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs:
|
"SILO PHARMA, INC. 2020 OMNIBUS EQUITY INCENTIVE PLAN",
"FIRST AMENDMENT TO EMPLOYMENT AGREEMENT This First Amendment to Employment Agreement is hereby entered into on January 18, 2021 and effective as of January 1, 2021 by and between SILO Pharma, Inc., a Delaware corporation and Eric Weisblum . The Corporation and Executive are collectively referred to herein as the “ Parties ”. WITNESSETH: WHEREAS, the Corporation and Executive are parties to that certain Employment Agreement dated as of April 17, 2020 ; WHEREAS, the Employment Agreement provided that Executive would be employed by the Corporation as Chief Executive Officer and Chief Financial Officer of the Corporation; WHEREAS, the Parties desire to amend the Employment Agreement to raise Executive’ s salary as set forth herein. NOW, THEREFORE, in consideration of the foregoing and for othe..." |
|
01/11/2021 |
8-K
| Quarterly results |
01/11/2021 |
8-K
| Quarterly results |
10/20/2020 |
8-K
| Quarterly results |
10/06/2020 |
8-K
| Quarterly results |
04/29/2020 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits |
04/21/2020 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office... |
01/22/2020 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
01/22/2019 |
8-K
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits |
12/20/2018 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi... |
|
|
|